PrintContact
 
  • Home
  • About Us
  • Sativex
  • R&D
  • Investors
  • Media
GW Pharmaceuticals

Meeting patients' needs...

Our vision

...is to be the global leader in prescription cannabinoid medicines, through the rapid cost-effective development of pharmaceutical products which address clear unmet patient needs.

 
PATIENTS

Therapeutic areas of focus, clinical trials and other information on Sativex...

Click here

 
MEDICAL PROFESSIONALS

Prescriber information, clinical publications and other information on Sativex...

Click here

 
MEDIA

Press releases, frequently asked questions and contact information for media enquiries...

Click here

 
INVESTORS

Share price, regulatory news, company presentations and other investor information..

Click here

 
 

Latest News

1 December 2009

Appointment of Piper Jaffray as Nominated Advisor & Broker

25 November 2009

Sativex® Phase II/III Cancer Pain Study Completes Patient Recruitment

News archive

Sportlight

ar front

Annual Report 2009

Click here to download the report

 
 
 
 

© GW Pharmaceuticals 2009

  • Home
  • Sitemap
  • Accessibility
  • Disclosure & Disclaimer
  • Contact
  • Email Alerts
 

Website designed and developed by www.emperordesign.co.uk